The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

MJ Page, JE McKenzie, PM Bossuyt, I Boutron… - Bmj, 2021 - bmj.com
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)
statement, published in 2009, was designed to help systematic reviewers transparently …

[HTML][HTML] Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

D Moher, L Shamseer, M Clarke, D Ghersi, A Liberati… - Systematic reviews, 2015 - Springer
Systematic reviews should build on a protocol that describes the rationale, hypothesis, and
planned methods of the review; few reviews report whether a protocol exists. Detailed, well …

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati… - Bmj, 2015 - bmj.com
Protocols of systematic reviews and meta-analyses allow for planning and documentation of
review methods, act as a guard against arbitrary decision making during review conduct …

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

MJ Page, D Moher, PM Bossuyt, I Boutron… - bmj, 2021 - bmj.com
The methods and results of systematic reviews should be reported in sufficient detail to allow
users to assess the trustworthiness and applicability of the review findings. The Preferred …

RoB 2: a revised tool for assessing risk of bias in randomised trials

JAC Sterne, J Savović, MJ Page, RG Elbers… - bmj, 2019 - bmj.com
Assessment of risk of bias is regarded as an essential component of a systematic review on
the effects of an intervention. The most commonly used tool for randomised trials is the …

[HTML][HTML] Practical methods for incorporating summary time-to-event data into meta-analysis

JF Tierney, LA Stewart, D Ghersi, S Burdett, MR Sydes - Trials, 2007 - Springer
Background In systematic reviews and meta-analyses, time-to-event outcomes are most
appropriately analysed using hazard ratios (HRs). In the absence of individual patient data …

Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement

LA Stewart, M Clarke, M Rovers, RD Riley… - Jama, 2015 - jamanetwork.com
Importance Systematic reviews and meta-analyses of individual participant data (IPD) aim to
collect, check, and reanalyze individual-level data from all studies addressing a particular …

Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data

LM Askie, L Duley, DJ Henderson-Smart, LA Stewart - The Lancet, 2007 - thelancet.com
Background Pre-eclampsia is a major cause of mortality and morbidity during pregnancy
and childbirth. Antiplatelet agents, especially low-dose aspirin, might prevent or delay pre …

Meta-analysis of the literature or of individual patient data: is there a difference?

LA Stewart, MKB Parmar - The Lancet, 1993 - Elsevier
The use of meta-analyses or overviews to combine formally the results of related
randomised clinical trials is becoming increasingly common. However the distinction …

To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data

LA Stewart, JF Tierney - Evaluation & the health professions, 2002 - journals.sagepub.com
Systematic reviews and meta-analyses that obtain original research data on individual
participants enrolled in trials have been described as the gold standard of review. However …